DexCom, Inc.

Headquarters: San Diego, CA, United States

Founded: 1999

Employees: 6,300

CEO: Mr. Kevin Ronald Sayer

show_chart NASDAQ: DXCM -2.97%

Market Cap

$49.13 Billion

USD as of July 1, 2023

history Market Cap History

DexCom, Inc. market capitalization over time

Evolution of DexCom, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of DexCom, Inc.

Detailed Description

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Product & Services

Medical devices

Key People

Kevin Sayer, CEO & President


Revenue: US$1.032 billion (2018)



6340 Sequence Drive

San Diego, CA 92121

United States

Phone: 858 200 0200